By Gale Scott
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
By Andrew Smith
A common treatment for opioid addiction significantly reduces testosterone levels in many male patients; researchers suggest that supplementary testosterone might improve outcomes.
For the second year running, physician turnover remains at the highest rate since 2005, according to a report published by the American Medical Group Association.
For physicians trying to balance various financial and time pressures, ethical dilemmas are common, according to an article published Aug. 7 in Medical Economics.
By Rachel Lutz
There is no link between vitamin D levels in infancy to adult-onset multiple sclerosis, according to research conducted by the Karolinska Institutet in Sweden.
By Gale Scott
An investigational drug that researchers hope will reverse nerve damage in patients with multiple sclerosis (MS) has been found to be safe and well tolerated in early trials. The big question is whether it will work, researchers said.
Treatment-naive patients with multiple myeloma frequently have sensory deficits, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Cerebrospinal fluid biomarkers for Alzheimer's disease, particularly β-amyloid 42 (Aβ42), are strongly associated with AD diagnosis, independent of APOE genotype, according to a study published online Aug. 27 in JAMA Psychiatry.
For patients with Parkinson's disease undergoing deep brain stimulation (DBS), increasing age does not impact complication rates, according to a study published online Aug. 25 in JAMA Neurology.
By B. Eliot Cole, MD, MPA
Looking back over a 30-year career in pain medicine, the author laments the shift from comprehensive, multidisciplinary pain care to a model that focuses on pills and procedures to treat chronic pain.